Abiopharma

INOVIO to Report First Quarter Financial Results on May 13, 2026

Dave & Buster’s Announces Board of Directors Transition

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Taitron Announces Quarterly Cash Dividend

Myomo to Report First Quarter 2026 Financial Results on May 7

InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System

Reinsurance Group of America Announces Redemption of All of Its Outstanding 5.75% Fixed-to-Floating Rate Subordinated Debentures Due 2056

Summary Notice of Proposed Settlement of Derivative Action

Angel Oak Financial Strategies Income Term Trust Declares May 2026 Distribution

GigCapital7 Corp. Announces Non-Redemption Agreements Funding in the Approximate Amount of at Least $19.3 Million in Conjunction with the Anticipated Closing of the Business Combination with Hadron Energy, Inc.

Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Demonstrating Durable Hormone Control, Reduced Glucocorticoid Exposure and Meaningful Clinical Improvements in Pediatric Patients with Classic Congenital Adrenal Hyperplasia

Upland Announces Commencement of New CEO Tenure and Inducement Awards

Origin Announces Plan to Sell Technology Followed by Orderly Wind Down of Operations

Asana to Announce First Quarter Fiscal Year 2027 Financial Results on Thursday, May 28, 2026